Vaccinex Stock Story

VCNX Stock  USD 7.45  0.10  1.32%   
Slightly above 61% of Vaccinex's investor base is looking to short. The analysis of the overall investor sentiment regarding Vaccinex suggests that many traders are alarmed. Vaccinex's investor sentiment overview provides quick insight into current market opportunities from investing in Vaccinex. The current market sentiment, together with Vaccinex's historical and current headlines, can help investors time the market. In addition, many technical investors use Vaccinex stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Vaccinex stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Vaccinex daily returns and investor perception about the current price of Vaccinex as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Vaccinex.

Vaccinex Latest Timeline

Vaccinex is listed for 7.45. The company reported the previous year's revenue of 620 K. Net Loss for the year was (22.01 M) with loss before overhead, payroll, taxes, and interest of (13.7 M).
When determining whether Vaccinex offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vaccinex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaccinex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vaccinex Stock:
Check out Vaccinex Hype Analysis, Vaccinex Correlation and Vaccinex Performance.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Vaccinex Stock analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Vaccinex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaccinex. If investors know Vaccinex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaccinex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(83.86)
Revenue Per Share
2.987
Quarterly Revenue Growth
(0.60)
Return On Assets
(2.58)
Return On Equity
(17.98)
The market value of Vaccinex is measured differently than its book value, which is the value of Vaccinex that is recorded on the company's balance sheet. Investors also form their own opinion of Vaccinex's value that differs from its market value or its book value, called intrinsic value, which is Vaccinex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaccinex's market value can be influenced by many factors that don't directly affect Vaccinex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaccinex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaccinex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaccinex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.